22 Dec Use of Oral Fluoroquinolones in Canada: A Drug Utilization Study Update
Posted at 14:25h
in
Use of Oral Fluoroquinolones in Canada: A Drug Utilization Study Update
HC0073
Overview
Background
- In January 2017, Health Canada issued a risk communication to restrict the use of fluoroquinolone antibiotics due to their potentially persistent and disabling side effects. Updates to the product labels were also made.
- It is unknown if fluoroquinolone utilization patterns have changed since these regulatory actions were implemented.
- At the request of Health Canada, our previous drug utilization study will be updated to determine if further regulatory actions are needed.
Objectives
- The main objectives of this study are to update our previous study to describe fluoroquinolone utilization trends from 2008 to 2022 and to assess the impact of the risk minimization measures introduced in 2017.